Fig. 1: Expression of Siglec-15 in different cancers by immunofluorescence (YTMA 395). | Laboratory Investigation

Fig. 1: Expression of Siglec-15 in different cancers by immunofluorescence (YTMA 395).

From: Quantitative assessment of Siglec-15 expression in lung, breast, head, and neck squamous cell carcinoma and bladder cancer

Fig. 1

A QIF score for Siglec-15 in the tumor compartment for the various tumor types. B QIF score for Siglec-15 in the stromal compartment for the various tumor types. C–J. Representative fluorescence images for Siglec-15 expression in tumor compartment for lung (C), breast (E), HNSCC (G) and bladder (I) and in stroma for the same (D), (F), (H), and (J).

Back to article page